Trials / Completed
CompletedNCT01596231
Kudzu Treatment for Alcohol Abuse
Isoflavone (Kudzu) Extract Effects on Alcohol Drinking: Single Dose Pretreatment Study
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Mclean Hospital · Academic / Other
- Sex
- All
- Age
- 21 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
This is a study designed to test whether a single administration of kudzu extract (2 mg) will significantly reduce the number of drinks consumed during a single 1 ½ hours drinking session when given as pretreatment 2 ½ hours before the drinking session.
Detailed description
In a laboratory experimental setting, subjects will be treated with placebo or 2 grams of kudzu extract 2.5 hours before an afternoon drinking session. The investigators hypothesis is that the kudzu pretreatment will reduce alcohol consumption in this free choice, self-administration paradigm.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Kudzu | Kudzu (2 mg) will be administered as a pretreatment 2 ½ hours before a drinking session to see if it will significantly reduce the number of drinks consumed during a single 1 ½ hours drinking session. |
| DIETARY_SUPPLEMENT | Placebo | Placebo will be administered as a pretreatment 2 ½ hours before a drinking session |
Timeline
- Start date
- 2010-05-01
- Primary completion
- 2013-05-01
- Completion
- 2014-07-01
- First posted
- 2012-05-10
- Last updated
- 2014-10-21
- Results posted
- 2014-10-21
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01596231. Inclusion in this directory is not an endorsement.